Legal Issues of Removing Patient From Practice Explored

Share this content:
Legal Issues of Removing Patient From Practice Explored
Legal Issues of Removing Patient From Practice Explored

(HealthDay News) -- The legal and ethical responsibilities of removing a patient from practice are discussed in an article published March 16 in Medical Economics.

The article discusses the concept of patient abandonment, defined as the unilateral severance of the physician-patient relationship by the physician, without giving the patient sufficient advance notice to obtain the services of another practitioner. Patient abandonment can result in significant liability, fines, and/or restrictions or loss of the physician's professional license.

To help protect the physician from liability and accusations of patient abandonment, the article recommends several strategies: provide written notice, clearly stating a termination date; include a list of suitable alternative providers; and time the termination appropriately, not at a time when the patient is in medical crisis. In addition, physicians should examine managed care contracts and communicate with health plans to check specifications concerning termination of the physician-patient relationship. Physicians should provide access to medical records for the new doctor. Finally, they need to inform everyone else in their practice of the termination to avoid inadvertent reestablishment of the physician-patient relationship.

"The treating physician should always be the one who makes the determination to terminate the physician-patient relationship rather than another staff member," according to the article. "By remaining personally involved, the physician can ensure that all of the above concerns are addressed appropriately."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »